Si Group, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PROPOFOL, with a corresponding US DMF Number 11777.
Remarkably, this DMF maintains an Active status since its submission on December 08, 1995, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2014, and payment made on January 09, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II